Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RUN domain-containing protein 3A (RUNDC3A) is a human protein encoded by the RUNDC3A gene. It belongs to the RUN domain protein family, characterized by the presence of the RUN domain that mediates protein interactions, notably with small GTPases. RUNDC3A has been described as a putative Rap2-interacting protein (RAP2IP), suggesting a role in GTPase-regulated cellular signaling processes. However, comprehensive functional characterization and its involvement in any disease process remain undefined. RUNDC3A is not currently recognized as a receptor, enzyme, transporter, or therapeutic target in clinical or drug development contexts.
None (No drugs target RUNDC3A)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RUN domain-containing protein 3A (RUNDC3A).